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Infertility is a health problem that affects approximately 7 million women in the United 
States (Ethics Committee of the American Society for Reproductive Medicine, 2015). 
Due to the high costs of reproductive medicine and infertility treatment, these services 
tend to be expensive and have limited accessibility without full insurance coverage. 
Emerging literature outlines the disparities in access to proper treatment for reproductive 
complications. These existing studies highlight that many minority populations in the 
United States experience increased challenges regarding access to reproductive medicine 
and infertility treatment. Among these minority groups are Hispanic women, who are 
more likely to require reproductive assistance than their Caucasian counterparts. 
However, due to economic and geographic barriers, these women are less likely to utilize 
assisted reproductive technology (ART). This paper will analyze the racial and ethnic 
disparities in access to reproductive technology and obstetric medicine affecting Hispanic 
women in the United States. The barriers in access to adequate healthcare resources will 
also be investigated, including socioeconomic status, communication differences, and 





reproductive techniques and discuss the best practices to prevent cultural stereotyping 
during treatment. 
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Assisted Reproductive Technology (ART) is used throughout the United States to 
promote pregnancy and overcome any possible fertility complications that may be 
preventing conception. ART includes any type of fertility treatment involving a woman’s 
eggs or an embryo. The surgical removal of a woman’s eggs is the main procedure of 
ART. The eggs are then usually combined with sperm in vitro and returned to a uterus, 
whether it be the same woman’s or a surrogate’s. The prevalence of ART has been 
increasing over the last few years and continues to expand as technologies improve. 
Specifically, the use of ART has doubled over the past 10 years, and about 1.7% of 
infants now born in the US are the result of this technology (CDC, 2020). Since this form 
of infertility treatment is still relatively uncommon due to its high cost and the novelty of 
its technologies, it is especially prone to disparity. According to the Ethics Committee of 
the American Society for Reproductive Medicine (ASRM), these medical disparities are 
often a consequence of social determinants such as race, socioeconomic status, and 
cultural stereotypes. These determinants affect many underrepresented populations in the 
United States, and this paper will analyze these negative effects on the Hispanic 
population specifically. 
The ASRM considers the ability to create a family a fundamental human right, so 
all populations should have adequate access to fertility treatments and reproductive 
technologies if needed. The ASRM has also proposed that “all ART stakeholders, 
including physicians, policymakers, and insurance providers, should address and lessen 





Reproductive Medicine, 2015). Many changes need to be implemented within the 
healthcare system to overcome existing healthcare disparities and infringements of 
fundamental human rights. These efforts should reduce the economic burden of fertility 
treatment and increase accessibility for those who need it. Physicians and healthcare 
providers must also improve their treatment and awareness of vulnerable populations and 
end any unintended biases or stereotypes that may be impeding treatment and adding to 
the disparities within reproductive medicine. 
 
 
II. Features of Assisted Reproductive Interventions 
The most common type of ART treatment is in vitro fertilization or IVF (CDC, 
2020). According to the Society for Assisted Reproductive Technology (SART), 99% of 
Assisted Reproductive Technology procedures are IVF (2020). In addition to IVF, ART 
also includes laboratory procedures such as gamete intrafallopian transfer (GIFT), zygote 
intrafallopian transfer (ZIFT), and frozen embryo transfer (FET) (Society for Assisted 
Reproductive Technology, 2020). According to the Society for Assisted Reproductive 
Technology, “ART may be recommended when other treatments (such as intrauterine 
insemination) have not been successful or when there is severe male factor infertility, 
severe endometriosis or tubal obstruction” (2020).  
Understanding the success rates of ART is important for patients seeking care. A 
2015 report conducted by the CDC found that almost 30% of ART cycles using a 
woman’s eggs led to pregnancy. Within this 30%, 70% were single pregnancies and 23% 





in miscarriage or stillbirth (CDC, 2017, WebMD, 2020). Many women suffer from 
fertility complications, including those in minority racial and ethnic groups who have 
shown evidence of higher infertility rates. These women may require ART procedures to 
promote pregnancy and create a family but face many barriers while receiving treatment. 
 
In Vitro Fertilization (IVF) 
In vitro fertilization, or IVF, is the most common and effective form of assisted 
reproductive technology. This procedure consists of removing and subsequently 
fertilizing a woman’s eggs, followed by implanting the embryo back into the woman’s 
uterus (CDC, 2020). One IVF cycle, which consists of egg removal, fertilization, and 
transfer, takes about 3 weeks (Mayo Clinic Staff, 2019a). Depending on the patient’s 
circumstances and fertility levels, she can decide whether to use her eggs, a donor’s eggs, 
or even a gestational carrier to carry her fertilized embryo. Success rates of IVF depend 
on the patient’s age and the cause of her infertility (Mayo Clinic Staff, 2019a). For 
example, IVF is most often used for patients with tubal infertility, issues with ovulation, 
uterine fibroids, or endometriosis. IVF is also a good option for couples experiencing 
impaired sperm function or genetic infertility (Mayo Clinic Staff, 2019a). These issues 
may arise due to genetic factors, environmental conditions, or infections such as 
chlamydia or other sexually transmitted infections. Some of these complications, such as 
genetic infertility, may be unavoidable, and affected couples may turn to ART when 
hoping to have children. 
The timeline of an IVF cycle is relatively complicated and requires multiple visits 
to the clinic. Before starting a cycle, a physician screens the patient and conducts a 





required to receive a semen analysis to promote successful fertilization (Mayo Clinic 
Staff, 2019a). Some patients may undergo a mock embryo transfer to determine the best 
route of embryo reinsertion. At the start of the IVF cycle, the patient or egg donor will 
begin hormonal treatment, stimulating egg production by the ovaries (Mayo Clinic Staff, 
2019a). This hormonal treatment usually consists of follicle-stimulating hormone (FSH), 
luteinizing hormone (LH), or a combination of the two (Mayo Clinic Staff, 2019a). These 
hormones cause the ovaries to produce multiple eggs rather than the single egg that the 
female ovaries produce each month, which increases the likelihood of a viable embryo as 
some eggs will not develop appropriately after fertilization. Other medications may be 
prescribed before egg removal, such as human chorionic gonadotropin, or HCG, which 
promotes egg maturation; progesterone, which helps prepare the uterine lining for 
implantation; and medications that prevent premature ovulation (Mayo Clinic Staff, 
2019a). To ensure that the eggs are ready for collection, the doctor will perform various 
tests such as a vaginal ultrasound or blood screening. Once the patient is prepared for egg 
retrieval, the doctor will conduct a transvaginal ultrasound to retrieve the eggs. During 
this procedure, the physician inserts an ultrasound probe into the patient’s vagina. Once 
the follicles are identified, a thin needle is inserted and used to retrieve the eggs (Mayo 
Clinic Staff, 2019a). 
The next step in the IVF cycle is fertilization. According to Mayo Clinic, there are 
two main methods of fertilization. Conventional insemination consists of the mixture of 
sperm and eggs, which is then incubated overnight. Intracytoplasmic sperm injection 
(ICSI), or the injection of a single sperm into each egg, may also be performed. This 





failed (2019a). Two to five days after egg collection and fertilization, the patient should 
be ready for embryo transfer. During this procedure, the doctor will insert a vaginal 
catheter into the patient’s uterus and use a syringe to place one or more embryos into the 
uterus (Mayo Clinic Staff, 2019a). If this process is successful, the embryo will implant 
into the uterine lining four to five days later. The doctor will most likely conduct a blood 
test about two weeks after egg retrieval to determine whether the patient is pregnant 
(Mayo Clinic Staff, 2019a). 
If the embryo does not implant, the patient may require additional cycles of IVF. 
Other IVF complications may include pregnancy loss, ectopic pregnancy, birth defects, or 
cancer that may arise from the additional hormonal supplements. In addition, if more than 
one embryo is transferred to the uterine lining, a multiple pregnancy may result, causing 
increased stress and complications for the patient (Mayo Clinic Staff, 2019a). The 
number of embryos implanted is usually determined by the patient’s age since the 
implantation rate is lower in older women. It is recommended that women who are 
younger than 38 years receive only one embryo because their chances of implantation are 
higher than those who are older (Mayo Clinic Staff, 2019a). In addition, a woman’s 
overall health is taken into account. A woman with a pre-existing condition may be 
vulnerable to the effects of a multiple pregnancy and should not receive more than a 
single embryo. If a patient does receive multiple embryos and more than one undergoes 
successful implantation, the patient may decide to receive a fetal reduction, but this may 








Gamete/Zygote Intrafallopian Transfer (GIFT/ZIFT) 
         Additional forms of assisted reproductive technology include gamete or zygote 
intrafallopian transfer (GIFT/ZIFT). These types of infertility treatments are essentially 
modified forms of IVF. Fundamentally, these procedures involve egg retrieval followed 
by fertilization and reinsertion, which is similar to IVF. In contrast, these procedures are 
less time-consuming than IVF. During the GIFT process, the eggs and sperm are simply 
mixed and inserted into the fallopian tubes, where fertilization will hopefully occur. With 
ZIFT, the fertilized eggs, or zygotes, are returned to the female’s fallopian tubes within 
24 hours, rather than after three to five days, as seen in IVF (WebMD, 2020). These 
treatment forms are effective for most infertility cases except for those caused by 
fallopian tube damage since reinsertion occurs here. 
         Before starting a GIFT cycle, the patient is treated with hormones to promote egg 
maturation and development. The eggs are also collected in the same manner as an IVF 
cycle. Unlike IVF, GIFT involves a surgical incision made in the patient’s abdomen. 
Following this incision, the eggs and sperm are immediately placed into the fallopian 
tube via laparoscopic injection, which requires general anesthesia (WebMD, 2020). Once 
the sperm and eggs are inside the fallopian tubes, at least one egg will hopefully be 
fertilized by the sperm. Following fertilization, the zygote will advance to the uterus for 
implantation and maturation. One drawback to GIFT is that it is impossible to determine 
whether fertilization has taken place, so the patient must wait until the embryo is 
implanted into the uterine lining. Because of this, more eggs are usually used to ensure 
implantation and subsequent pregnancy. Conversely, this may also increase the chances 





         The ZIFT procedure is very similar to GIFT; the patient will be treated with 
hormones and undergo a surgical incision followed by laparoscopic injection into the 
fallopian tubes. The only difference is that the eggs are fertilized before reinsertion. The 
eggs and sperm are mixed and incubated for approximately 24 hours, allowing 
fertilization before being returned to the patient’s fallopian tubes. This treatment method 
uses fewer eggs and lowers the risk of multiple pregnancy compared to GIFT because 
fertilization is determined prior to reinsertion (WebMD, 2020). 
         GIFT and ZIFT may be preferred to IVF because the processes are more similar 
to natural conception since the gametes or zygotes are placed into the fallopian tube 
rather than the uterus. GIFT is even more similar to natural conception because 
fertilization occurs in the woman’s body rather than in vitro (WebMD, 2020). In contrast, 
IVF may be the preferred choice since it does not entail a surgical incision. GIFT and 
ZIFT are also more expensive than IVF, costing between $15,000 to $20,000, compared 
to approximately $12,000 per IVF cycle. Each of these treatments’ costs depend on the 
number of cycles needed, the medications given, and the amount covered by insurance 
(WebMD, 2020). Due to the higher prices and increased invasiveness of GIFT and ZIFT, 
these procedures only account for about 2% of ART interventions (WebMD, 2020).  
 
Frozen Embryo Transfer (FET) 
         The final commonly used form of ART is frozen embryo transfer or FET. This 
process uses an embryo from a previous IVF cycle that has been frozen and saved for 
future use (“Frozen Embryo Transfer”, 2020). According to the article titled “Frozen 
Embryo Transfers (FET) Explained”, “about 40 percent of patients who undergo IVF 





attempt, should their first cycle be unsuccessful, or to continue to build their family at a 
later date” (“Frozen Embryo Transfers (FET) Explained”, 2016). After undergoing an 
IVF cycle, the patient may choose to have her extra embryos frozen as long as they’ve 
survived to the blastocyst stage, which usually occurs around day five. The embryos are 
then frozen via vitrification, which consists of the embryo’s placement into a solution and 
then quickly freezing it in liquid nitrogen. This process prevents embryo breakage and ice 
crystal formation, allowing for a higher survival rate and increasing the chance of 
pregnancy (“Frozen Embryo Transfers (FET) Explained”, 2016). When the patient 
eventually decides to use her frozen embryos, she will start a cycle similar to IVF, 
consisting of uterine examinations and ultrasounds to ensure proper conditions for 
embryonic development. She will also receive hormonal injections such as estrogen and 
progesterone to promote the growth of the uterine lining. Compared to IVF, patients 
undergoing FET receive fewer medications, which may lower the chances of medical 
complications. Thawing only takes about an hour, and the embryo is implanted into the 
patient’s uterine lining (“Frozen Embryo Transfer”, 2020). The transfer process is 
substantially less time-consuming than IVF, making it a good option after one or more 
failed IVF attempts as long as embryos have been saved for later use. 
         FET is commonly used to avoid a hormonal phenomenon called 
desynchronization. During IVF, estrogen and progesterone levels are increased, and the 
rise of the latter promotes the development of the uterine lining (“Frozen Embryo 
Transfer”, 2020).  During an IVF cycle, these hormone levels may rise too quickly, 
preventing the uterine lining from adequately supporting the implanted embryos. This 





called desynchronization, which decreases the chances of successful implantation 
(“Frozen Embryo Transfer”, 2020). FET is used to avoid this issue because hormone 
levels are allowed to return to normal before implantation, which increases the chances of 
a successful pregnancy. The embryos may implant once the uterine lining has recovered 
from the hormonal stresses of a standard IVF cycle. FET is a good option for patients 
who have had previous failed IVF cycles because many clinics offer this service as part 
of a standard IVF treatment.  
 
III. Infertility Rates of Populations 
According to a study conducted by the National Survey of Family Growth 
(NFSG), infertility can be defined as “failure to achieve pregnancy after 12 months of 
unprotected intercourse” (Quinn & Fujimoto, 2016). Approximately 6.7 million 
American women in the United States are negatively affected by infertility (Ethics 
Committee of the American Society for Reproductive Medicine, 2015). While about 11% 
of American women experience infertility, an additional 9.4% of American men are 
considered subfertile or sterile (Ethics Committee of the American Society for 
Reproductive Medicine, 2015). The high prevalence of infertility in our country leads to 
an increased need for infertility treatments, such as ART. Analyzing the data reported by 
infertility clinics across the United States gives valuable information regarding the 
overall accessibility and success rates of these treatments.  As of 2010, 474 ART clinics 
were operating in the United States. 93.5% of these clinics report their data directly to the 
CDC, while the remaining 6.5% are considered non reporters (Williams et al., 2015). 





treatments were performed within 448 of these reporting clinics. These treatments 
resulted in the birth of approximately 70,000 infants (CDC, 2020). The American Society 
for Reproductive Medicine (ASRM) and the Society for Assisted Reproductive Medicine 
(SART) sparked ART data collection efforts, and the CDC is currently working to 
monitor and improve the use of data collection (CDC, 2019). The efforts of the ASRM, 
SART, and CDC allow for the in-depth analysis of fertility rates and ART utilization 
among patients in the United States. 
         Since minority groups account for a small portion of infertility patients, it is 
difficult to determine the exact prevalence of infertility among the Hispanic population. 
While various studies have illustrated higher rates of infertility among non-Caucasian 
women, the exact degree to which Hispanic women are affected is unknown. The 
duration of infertility is higher among Hispanic women, with an average of 58 months, 
compared to 38 months for Caucasian women and 35 months for African American 
women (USC Fertility, 2021). The combination of prolonged infertility and decreased 
utilization of services exemplifies the need for reform to promote access to treatment. 
Additional studies must be conducted to determine whether Hispanic Americans are 
affected to a higher degree. Still, treatment protocols and insurance coverage should be 
adjusted to encourage the use and success rates of all infertility patients, especially those 
in minority groups who experience limited access to care and lower socioeconomic 
standing. While the relationship between race and infertility is poorly studied, researchers 
and providers can analyze existing information and causal factors to determine where 
racial and ethnic disparities exist and improve the accessibility of reproductive 





IV. Biological Explanation of Hispanic Fertility Rate 
IVF implantation research has shown that minority groups, including African 
American, Asian, and Hispanic women experience lower rates of successful implantation 
than their Caucasian counterparts due to complications including uterine fibroids and 
tubal-factor infertility. These medical issues exemplify the necessity for accessible 
fertility treatment options. Studies have also found evidence supporting lower pregnancy 
rates and higher miscarriage rates among these minority groups (Ethics Committee of the 
American Society for Reproductive Medicine, 2015). While behavioral and 
environmental factors have the most prevalent effects on the fertility rates of these 
populations, research has found that there may also be a biological explanation resulting 
in lower fertility rates of minority populations.  
Uterine fibroids, also known as uterine leiomyomas, or ULMs, are benign tumors 
that grow in the smooth muscle cells within the uterine wall. These tumors are very 
prevalent and affect about 77% of the female population (Othman et al., 2008). Though 
they are common among females in general, they are especially prevalent in African 
American and Hispanic women. Hispanic and African American women are over twice 
as likely to develop ULMs than white women (Othman et al., 2008). The exact causes of 
ULMs are unknown, but they are most likely due to environmental factors that interact 
with existing genetic mutations and give rise to mutated uterine lining cells. These 
fibroids often arise due to the increased production of estrogen and progesterone, which 
stimulate the growth of the uterine lining. If the cells of the lining begin to exhibit 
uncontrolled growth, these fibroids may arise (Mayo Clinic Staff, 2019b). The presence 





(Mayo Clinic Staff, 2019a). ULM’s may cause difficulties with conception, leading to the 
potential need for ART services. Minority women are more likely to develop uterine 
fibroids but are less likely to utilize ART services due to lack of access. This relationship 
shows the essential need for reform to promote the use of these services among minority 
populations. 
Further research has found that Hispanic women are also more likely to require 
ART due to a higher incidence of tubal-factor infertility (Schuler et al., 2011, Armstrong 
& Plowden, 2012). Tubal-factor infertility occurs when either one or both fallopian tubes 
become blocked or damaged. This can potentially prevent fertilization of the egg and 
increase the woman’s risk of ectopic pregnancy or the implantation of a fertilized egg 
within the fallopian tube (CCRM Fertility, 2020). Of all IVF patients, approximately 30% 
seek treatment due to high tubal infertility prevalence (Insogna & Ginsburgm, 2018). 
According to Fujimoto et al., Hispanic women experience a higher probability of being 
diagnosed with tubal factors than white and African American women (2008). In a study 
conducted by Tarun Jain, 27.3% of surveyed Hispanic women had tubal infertility 
compared to 24% of African American women and only 5.3% of Caucasian women 
(2006). One possible explanation for these high tubal-factor infertility rates is the higher 
prevalence of sexually transmitted infections (STIs) among Hispanic and other minority 
populations. Jain’s study found that African American and Hispanic women who had 
been diagnosed with STIs were more likely to suffer from tubal-factor infertility (2006). 
Tubal damage may result from any biological stress, such as previous ectopic pregnancy, 
but one common cause of damage are sexually transmitted infections such as chlamydia 





explaining the higher prevalence of tubal infertility in this population (Insogna & 
Ginsburgm, 2018). The correlation between STI rates and tubal-factor infertility 
exemplifies the importance of sexual education and public health measures for vulnerable 
minority populations. 
         In addition to a higher prevalence of tubal-factor infertility, Hispanics and other 
minority women are less likely to carry to term. Fujimoto et al. discovered that Hispanic 
women experienced higher rates of fetal loss compared to white women and were 13% 
less likely to have a live birth. Hispanic women were also 22% more likely to deliver 
their child preterm (2008). Similarly, Hispanic women are eight times as likely to have an 
ectopic pregnancy than their Caucasian counterparts. The higher incidence rates of these 
populations do not have a clear explanation and have not been thoroughly studied. Still, 
evidence suggests that most complications arise in response to tubal factor infertility or 
previous damage to the reproductive system (Schuler et al., 2011). The additional 
conception complications experienced by Hispanic and other minority groups highlight 
the need for increased education and reform to promote access to infertility services and 
conception assistance. Comparing the higher chances of complications to the low rates of 
utilization can illuminate the racial disparities in access to reproductive care in the United 
States. 
 
V. Utilization of Services Among Hispanic Populations 
While few biological factors have been found to dramatically decrease the fertility 
rate of Hispanic populations, many environmental and behavioral factors lead to a lower 





socioeconomic and geographic factors, which ultimately affect the overall availability of 
reproductive medicine. In general, Hispanics are much less likely than whites to have a 
primary care provider, who would be responsible for referrals for higher-level treatment 
(Hargraves et al., 2001). According to José Escarce and Kanika Kapur, over one-third of 
Hispanic immigrants lack a primary healthcare source (2006). While anyone is able to 
receive medical care in public emergency units if needed, they are less likely to be 
referred to specialized care. Studies have found that Hispanics experience lower access to 
healthcare specialists, such as reproductive endocrinologists. A 1997 Community 
Tracking Study household survey found that only 73.5% of Hispanics had visited a 
regular provider in the last year, compared to almost 80% of African Americans and 91% 
of whites. This same survey found that only 22.3% of Hispanics had their last visit with a 
healthcare specialist compared to 27.5% of whites (Hargraves et al., 2001). The low 
utilization of specialized medicine among Hispanic populations compared to other racial 
groups hints at possible barriers impeding access to these fields. Though the healthcare 
gap between ethnic groups has been narrowing, Hispanics have been found to have less 
access to prenatal care and fertility services (Escarce & Kapur, 2006). Of the patients that 
utilize infertility treatment options such as ART, a disproportionately large percentage 
were Caucasian women. A study conducted between 2006 and 2010 found that 15% of 
white women utilized ART compared to a mere 7.6% of Hispanic women (Copen & EH, 
2010, Quinn & Fujimoto, 2016). Within the United States, Hispanics make up over 12% 
of the general population, but only 5.4% of ART patients (Quinn & Fujimoto, 2016). 
According to the Ethics Committee of the American Society for Reproductive Medicine, 





of the population, it is considered a health disparity” (2015). On average, Hispanic 
women attempt conception for 1.5 years longer than white women and experience 
increased challenges to make an appointment and pay for infertility treatment (Missmer 
et al., 2011). Understanding the sociodemographic factors that limit Hispanic utilization 
of assisted reproductive technologies will promote the fight to end these health 
disparities, promising equitable healthcare and human rights among all minority groups. 
 
VI. Geographic Distribution of Reproductive Care 
One of the most prevalent factors affecting the lower rates of ART utilization 
among Hispanic women is the geographic distribution of specialized medical services. 
Quinn and Fujimoto confirm that “geographic distribution of obstetrician-gynecologists 
and IVF centers varies, and these services may not be physically accessible to many 
groups” (2016). Since these medical facilities may be far from one’s place of residence, 
patients must afford to take time to travel and receive care. ART services generally 
require multiple clinic visits, so travel could potentially become expensive and time-
consuming. Understanding the geographic barriers that prevent Hispanic women from 
seeking infertility treatment can help promote the accessibility of specialty care and 
reproductive services. 
Distribution of Physicians and Specialists 
Healthcare specialists are generally located in more affluent urban areas, causing 
Hispanics tend to experience lower access to specialized medical interventions. Studying 
the distribution of medical specialists may uncover geographic gaps in access to care. 





higher rates of physician shortages, regardless of community income level. Communities 
with predominantly Black and Hispanic populations were found to be 4 times as likely to 
experience a scarcity of practicing physicians (Komarony et al., 1996). This lack of 
physicians is not limited to areas of low socioeconomic status and directly relates to the 
predominant race of the community. According to research conducted by Komarony et 
al., “Urban areas of poverty that had neither a high proportion of black nor a high 
proportion of Hispanic residents had nearly three times as many primary care physicians 
per capita as areas with high proportions of both black and Hispanic residents” (1996).  
Furthermore, this trend was not limited to urban areas. The same study found that 
the number of practicing physicians was lower in rural areas with higher percentages of 
minority groups (Komarony, et al., 1996). This trend is most likely due to the high 
prevalence of white physicians who choose to practice medicine in affluent communities, 
which are predominantly white due to socioeconomic factors. Hispanic communities 
have exhibited a similar trend, as Hispanic doctors care for three times as many Hispanic 
patients as other patients (Komarony et al., 1996). This preference for treating patients of 
the same race could potentially explain the underutilization of ART among Hispanics 
since Hispanics only compose 5.8% of the physician workforce in the US (Association of 
American Medical Colleges, 2019). The low prevalence of practicing Hispanic 
physicians can be explained by analyzing the disparities in socioeconomic status and 









         Studying the geographic distribution of ART clinics can allow us to better 
recognize existing disparities in access to care. In the United States, 442 ART clinics are 
located within 76 metropolitan areas, each with an average population of approximately 
1.45 million people (Harris, et al.). Reports have shown that ART clinics and 
reproductive specialists are concentrated in areas with high populations and high-income 
levels (Harris et al., 2017). These clinics are concentrated in highly populated 
metropolitan areas, but approximately 30% of the U.S. population lives in areas with 
nonexistent access to ART clinics. Furthermore, almost 40% of the U.S. population, or 
over 25 million reproductive-age women, have limited or absent access to ART services 
(Harris et al., 2017). This information is crucial because it allows us to analyze the 
additional barriers that women face when seeking infertility treatments, especially in 
minority populations where access is further limited. Patients who have limited access to 
ART clinics face added barriers including travel time, reduced social support from fellow 
ART patients, and longer waiting times to receive care (Harris et al., 2017). The extended 
commute time also places additional financial barriers on these women, as they are 
expected to take time off from work and acquire transportation to appointments. 
Examining the limited access to specialty physicians and ART clinics can help promote 
the creation of additional clinics and assistance programs to allow minority women to 
receive care that may be currently inaccessible. 
 
Distribution of Hispanic Population 
         According to the U.S. Census Bureau, Hispanics made up approximately 18% of 
the U.S. population in 2017. Out of 323 million Americans, over 57 million are of 





population tends to be concentrated mainly in Western states, the three states with the 
highest Hispanic populations are California (15.3 million), Texas (10.9 million), and 
Florida (5.1 million). California has the largest Hispanic population, but New Mexico has 
the highest proportion of Hispanic residents relative to its overall population (U.S. 
Census Bureau, 2017, Hernández-Nieto & Gutiérrez, 2017). Looking forward, the 
Hispanic population in the United States is projected to grow considerably. A report 
published in 2016 by Stepler and Lopez found that the Hispanic populations in 
Pennsylvania, New Jersey, and New York had the highest growth between 2000 and 
2007. However, the top three counties with the highest Hispanic population growth were 
all found in North Dakota (2016, Hernández-Nieto & Gutiérrez, 2017). Overall, the US 
census bureau predicts that the Hispanic population will rise from 57 million to 106 
million by the year 2050, raising the overall percentage of Hispanics from 17.8% to 
26.6% (2014, Hernández-Nieto & Gutiérrez, 2017). In addition, the Hispanic population 
in the United States is remarkably young. While the median age of the U.S. population is 
37.9 years, the median age of Hispanic-Americans is 28.9 years (American FactFinder, 
2016, Hernández-Nieto & Gutiérrez, 2017). This information shows that a high 
proportion of Hispanics are current or future reproductive-aged women who may need 
extra assistance with successful conception. The high population levels and the young 
average age of Hispanics in the US exemplify the importance of healthcare equity and the 
availability of specialized reproductive medicine. Understanding the geographic 
distribution of Hispanics and other minority populations helps better understand existing 







VII. Socioeconomic Barriers in Hispanic Populations 
In addition to the geographic distribution of ART clinics compared to the 
Hispanic population, socioeconomic factors also serve as barriers to reproductive 
technology among minority groups. Primarily, fertility services are costly, which further 
adds to the disparities of the field. Quinn and Fuijimoto confirm that “the cost of care has 
been identified as the greatest barrier to access to infertility care in the U.S.” (2016). 
According to Armstrong and Plowden, IVF treatments in the US cost over $12,000 per 
cycle, and the additional cost of birth without insurance is over $40,000, though this 
typically receives coverage (2012). Chambers et al. report that one IVF cycle can cost up 
to 50% of the average annual disposable income in the United States (2009). Of ART 
patients studied in Massachusetts, over 60% had an annual household income above 
$100,000 (Quinn & Fujimoto, 2016). The high cost of ART is problematic for minority 
populations, especially since 68.2% of the Hispanic population in the US has an annual 
household income of less than $100,000 (Jain, 2006). The average income of Hispanic-
American households is about $42,000, compared to over $60,000 for white families 
(DeNavas-Walt, 2014, Quinn & Fujimoto, 2016). While IVF is the most expensive ART 
option, other infertility treatments “may also be above the reach of those in lower-income 
categories which tend to disproportionately include ethnic and racial minorities” (Quinn 
& Fujimoto, 2016). 
Within the population of infertility patients, Hispanics are disproportionately 
underrepresented (Ethics Committee of the American Society for Reproductive Medicine, 





white women of high educational and socioeconomic standing. A study conducted by 
Escarce and Kapur has concluded that 23% of Hispanics lived under the poverty line in 
1999, compared to only 8% of whites (2006). Due to the high cost of infertility 
treatments, patients tend to be of high socioeconomic status, allowing them to afford 
these specialized treatments. Wellons et al., confirm that “women who undergo assisted-
reproductive technologies (ART) have higher education and incomes than the general 
population and greater access to medical care” (2012). Income, education level, and 
insurance rates are three main socioeconomic factors that explain the racial and ethnic 
disparities in reproductive medicine. 
 
Education Levels 
Since education levels are usually positively correlated with overall income and 
socioeconomic status, education can be analyzed as a factor that affects healthcare 
disparities in the United States. According to Rosana Hernández-Nieto and Marcus 
Gutiérrez, “a higher level of education is correlated with higher income, better job 
prospects, higher proficiency in the English language, and better quality of life 
indicators” (2017). In 1999, only 56% of Hispanics had completed high school compared 
to 88% of whites (Escarce & Kapur, 2006). Studies have shown that Hispanics are 
generally the least likely population to achieve each level of education. These challenges 
are most likely due to the additional financial burden faced by this population, preventing 
them from pursuing higher education (Hernández-Nieto & Gutiérrez, 2017). In the 
United States, Hispanics are more likely to be employed in low-wage fields including 
agriculture, construction, domestic services, and other industries that do not require high 





population in an ongoing cycle of limited access to higher education and low 
socioeconomic status. A study conducted by Jain found that about 41% of Hispanic 
women studied had less than a 4-year college degree compared to only 13.2% of white 
women (2006). When looking at patients who receive infertility treatments such as ART, 
none of the patients had less than a high school degree, and almost half of the patients 
possessed advanced degrees (Quinn & Fujimoto, 2016). The educational disparities 
among potential ART patients can help explain the lack of utilization among Hispanic 
populations, as education level generally correlates with socioeconomic status and 
average household income. By alleviating the financial burden on infertile minority 
women, racial and ethnic minorities will receive necessary infertility treatments, 
overcoming existing inequities in reproductive medicine. 
 
Insurance Coverage 
The primary cause of Hispanic underrepresentation as ART patients is the lower 
prevalence of health insurance coverage in Hispanic populations and the overall lack of 
coverage for infertility in the United States. Patients with public or federal insurance do 
not receive coverage for infertility treatments, adding financial barriers to these minority 
populations when seeking ART treatment (Insogna & Ginsburgm, 2018). Within the 
United States, many IVF and other ART patients are forced to pay out-of-pocket due to 
limited insurance coverage for infertility treatment services. According to Jain, infertility 
treatments remain privately funded in many states, and they are not covered by insurance 
because it treats a preexisting condition or may not be medically necessary (2006). Even 
with standard insurance coverage, the average IVF cycle would still cost about 44% of 





2009). While insurance coverage would significantly increase ART availability, 
socioeconomic inequalities would also continue to exist among the racial groups 
receiving infertility treatments. Insogna and Ginsburgm explain that “for most people, 
paying for ART out of pocket is impossible, leaving many without a financially feasible 
way to manage their disease or achieve their reproductive goals” (2018). 
Even though a physician may do their best to provide effective care to all patients, 
their hands may be tied due to the shortcomings of healthcare economics. The lack of 
coverage for infertility treatment makes it very difficult, if not impossible, for providers 
to reach patients of lower socioeconomic standing. Even if a specific insurance plan 
offers coverage for ART treatments, Hispanics are less likely than whites to have any 
source of coverage. A 2004 study found that only 64% of Hispanics had health insurance 
compared to 85% of whites (Rhoades, 2005, Escarce & Kapur, 2006). Upon analyzing 
the insurance rates of different Hispanic populations, studies have found that rates 
broadly vary according to each subgroup. For example, Olveen Carrasquillo et al. have 
shown that Mexican Americans and Cuban Americans have higher uninsurance rates than 
other Hispanic subgroups. Factors that most strongly influence the insurance rates of 
these populations are citizenship status, income level, and time spent in the United States 
(2000). Due to this lack of coverage, Hispanics rely more strongly on public clinics and 
outpatient departments than primary physicians or specialty clinics (Doty, 2003, Escarce 
& Kapur, 2006). 
While a handful of states, including Connecticut, Illinois, Maryland, 
Massachusetts, New Jersey, and Rhode Island, provide insurance coverage for infertility 





excluded from this coverage (Quinn & Fujimoto, 2016). Over 17 million Hispanics in the 
US receive insurance from Medicaid, and they make up over one-third of the Medicaid 
enrollees (National Committee to Preserve Social Security and Medicare, 2020). The 
high proportion of Hispanics covered by Medicaid or not covered at all is forced to pay 
for these expensive infertility treatments out of pocket, which may not be an option for 
most couples. Many women who would benefit from IVF and other therapies cannot 
receive treatment due to financial constraints or limited access to specialty clinics (Jain, 
2006). Studies have shown that insurance coverage for IVF would increase utilization 
rates by 277%, benefitting many women and couples who desire to create a family (Jain, 
2006). Existing disparities in access to ART services could be drastically minimized by 
policy changes that include infertility treatment in insurance coverage, lessening the 
financial burden on Hispanic and minority populations seeking treatment. 
 
VIII. Social Stigmas within Hispanic Populations 
Compared to white women, surveys have found that Hispanic and other minority 
women are more concerned about the stigma associated with being labeled “infertile”. 
According to a study conducted by Missmer et al., minority women were seven to 18 
times more likely than white women to be concerned about the stigma of infertility 
(2011). These deep concerns may be partially responsible for the low utilization rate of 
ART among Hispanic and other minority populations. The Ethics Committee of the 
ASRM reports that researchers who have studied minority populations, including 
Hispanics, notice that “communication differences, cultural stigmas (including male and 





unfamiliarity or prior bad experiences with the US medical system” play a role in the low 
utilization rates of ART (2015). In addition, the concern regarding the stigma of 
infertility also affects the support system available for these women. According to 
Missmer et al., these women are often less likely to communicate their health problems 
with friends and family due to the shame of being infertile, limiting the potential for 
medical referrals and informal support (2011). Religion and family values are 
fundamental within the Hispanic culture, and these factors are primarily responsible for 
concern over the cultural and social stigmas of infertility.  
 
Influence of Religion 
Historically, Hispanic populations tend to be mainly dominated by the Catholic 
faith. In 2014, almost 50% of the Hispanic population of the United States identified as 
Catholic. An additional 19% identified as Evangelical Protestant, while the remaining 
33% was distributed over many other Christian and Non-Christian faiths. This study also 
found that religion is either somewhat important or very important to 84% of Hispanics 
(Pew Research Center, 2020). The influence of religion among Hispanic populations may 
be a decisive factor in the concern regarding the infertility stigma. In a 2009 study on the 
cultural stigma of infertility treatment, Culley et al. noted that over 85% of Hispanics in 
his study group were Catholic. They were found to possess strong beliefs that having 
children was their duty under God. The men and women in the study also believed that 
having a child was the basis of their relationship and were often demoralized if 
conception did not occur (2009). Among infertile patients, the failure to meet the 
religious expectation of creating a family leads to powerful feelings of embarrassment, 





conception will eventually occur with perseverance, prevent these couples from seeking 
further treatment. These religious influences lead to additional concern and aversion to 
seeking infertility treatment and ART procedures. 
The religious stigma and feelings of failure surrounding infertile women are 
major barriers to seeking ART therapies, but the Catholic Church’s aversion to ART and 
reproductive interventions is a prevalent cultural barrier to receiving treatment. Dr. 
Joseph Stenker explains that, “According to the Catholic Church Doctrine, procreation 
may not be performed by the physician” (2005). Furthermore, Pope Pius XXII asserted in 
1956 that IVF is an immoral and unacceptable means to conception (Stenker, 2005). 
Since Catholicism places a high emphasis on the marital duty of creating a family, the 
Church views IVF as a “disregard of human life” (Stenker, 2005). The Catholic Church’s 
strict aversion to ART treatments may be responsible for the underuse of reproductive 
medicine among the Hispanic demographic, since this population is predominantly 
Catholic. 
Cultural Expectations 
Along with the Catholic faith, Hispanic tradition and culture place a strong 
emphasis on constructing a family. Because of this influence, infertile Hispanic couples 
experience increased marital conflict and reluctance to seek treatment to avoid being 
labeled “infertile”. According to Culley et al., “childless marriages were considered a 
failure, there was a widespread expectation that a relationship would end if no children 
were ever born. Women and men were demoralized by repeated failures to conceive and 
increased fault-finding with each other” (2009). Because parenthood and the creation of a 





incomplete. This often led to marital conflict as each partner begins to blame the other for 
failure to conceive. In addition, Hispanic culture places high responsibility on women to 
raise their children. While this is a very traditional belief, it undoubtedly exists today. 
Within many modern Hispanic families, the woman is mainly responsible for household 
affairs including cooking, cleaning, and caring for the children. At the same time, the 
man is expected to work and earn money for his family. This stigma has changed 
drastically over the years as women have gained educations and financial independence, 
but many women still hold the majority of the responsibility for raising their children. 
Understanding specific cultural beliefs and values allows providers to fully grasp the 
feelings and attitudes of the demographic they serve. For example, Culley et al. write that 
marianismo is the Hispanic belief that “a woman’s self-esteem is manifested in her 
ability to be a generous mother” (2009). The failure to meet this cultural expectation 
could drastically affect a woman’s self-esteem and worsen the social and cultural stigmas 
surrounding her infertility. Normalizing treatment by making ART clinics more 
accessible and providing educational programs to increase awareness could dramatically 
improve the well-being of infertile couples by giving them the chance to create a family 




IX. Communication Barriers 
Communication plays a vital role in the healthcare field, especially when 





the accessibility and delivery of medicine, so adequate strides must be taken to treat all 
patients and ensure health equity. The Ethics Committee of the ASRM states that, 
“researchers who have studied African American, Hispanic, Muslim, and Asian 
populations in the United States have noted that communication differences (…) can 
dissuade members of certain racial, ethnic, or religious groups from seeking care for 
infertility” (2015). Since the Hispanic population is one of the fastest-growing ethnic 
groups in the United States, there is no reason that communication barriers should 
prevent them from receiving care. Hernández-Nieto and Gutiérrez explain that after 
English, Spanish is the most widely used language in the United States with over 40 
million speakers, excluding undocumented immigrants. This number places the United 
States as the second country with the highest number of Spanish speakers, only behind 
Mexico (2017). Despite these statistics, Molly Quinn and Victor Fujimoto report that 
minority populations face increased challenges when seeking infertility services due to 
increased communication barriers (2016). Infertility treatment can be extremely daunting 
to non-English speakers, leading to the low utilization of ART among Hispanic 
populations. Minority patients often experience challenges such as understanding 
diagnoses and communicating their concerns to their healthcare providers while seeking 
treatment (Quinn & Fujimoto, 2016).  If a patient is uncomfortable receiving medical 
treatment due to communication barriers, interpreters and translators should be available 
to allow them to utilize these services. Physicians and healthcare providers should also 
increase their cultural competency and awareness to best treat their patients. 
In general, infertility patients are often unsatisfied with their physician 





infertility patients viewed their physician interactions as insufficient, despite claiming 
that proper communication is critical for effective care (2018). Many of these patients 
were unsatisfied with physician interactions because they were “wary of the sterile, 
mechanical procedures and routinization” of infertility treatments (Klitzman, 2018). 
These patients reported feeling “a lack of empathy” from the physicians and staff 
members in the clinic (Klitzman, 2018).  Moreover, a study conducted by Dancet in 2011 
found that infertility patients would trade almost 10% of their possible pregnancy rates in 
exchange for a friendly and empathetic doctor, affirming the importance of effective 
communication and respect while performing ART procedures (2011, Klitzman, 2018). 
Overall, infertility physicians should emphasize patient-centered care, especially when 
communication barriers may already be present. Klitzman also stresses that physicians 
must effectively communicate the statistics of IVF success rates to avoid raising the 
hopes and expectations of their patients, avoiding future disappointment in the case of a 
failed cycle (2018). Physicians must be able to communicate the psychological and 
emotional difficulties involved in ART procedures and be prepared to interact with their 
patients empathetically in the case of miscarriage or a failed cycle. This sense of empathy 
may be lost in translation without a trained medical interpreter, which is a major reason 
for facilities to employ professional interpreters rather than relying on untrained 
interpreters or family members. 
Use of Interpreters 
         As the United States becomes more diverse, language interpreters in the 
healthcare field are becoming increasingly vital. While this is the case, Cheri Wilson 





Appropriate Services (CLAS) for Limited English Proficient (LEP) patients (2013). 
While the Civil Rights Act of 1964 considers “the denial or delay of medical care due to 
language barriers to be discrimination” and the U.S. Department of Health has issued 
national standards for linguistically appropriate services, communication continues to be 
a barrier for minority populations receiving healthcare (Wilson, 2013). Flores et al. report 
that only 23% of teaching hospitals educate their physicians about properly engaging 
with an interpreter (2003, Wilson, 2013). Moreover, many hospitals may not have a 
formal interpreter on hand, forcing untrained interpreters or family members to step in 
and communicate for the patient. Rose et al. report that only 42% of physicians who had 
worked with LEP patients in the last 12 months had used a trained interpreter. 75% of 
these physicians had used untrained interpreters to communicate with these patients 
(2010). The use of unqualified interpreters can raise privacy issues, especially in the 
invasive field of reproductive medicine. According to Flores et al., this can lead to an 
increase in interpretation errors that may have highly adverse consequences (2003, 
Wilson, 2013). The Institute of Medicine explains that these consequences may entail 
“misunderstanding of a patient’s concerns, misdiagnosis, unnecessary testing, poor 
patient compliance, inappropriate follow-up, and poor patient satisfaction” (2002, 
Wilson, 2013).  
The only way to provide adequate care for non-English speakers is to employ 
trained interpreters who can capably communicate with patients in their preferred 
language. It is also important for trained interpreters to maintain the sense of empathy 
that the provider wishes to portray. These feelings and emotions are likely lost when 





when receiving care. Untrained interpreters may also lack proper medical knowledge and 
violate patient confidentiality and privacy (Wilson, 2013). Especially in reproductive 
medicine, privacy is critical, and patients may not want untrained interpreters to be 
involved in the discussion of sensitive issues. According to Decola (2016), “healthcare 
professionals face potential civil liability when they fail to provide qualified interpreters'', 
especially if confidentiality is breached or if the patient receives improper medical care as 
a result (Gaurab et al., 2017). To overcome this lack of interpreter availability, hospitals 
and medical institutions should provide trained interpreters, whether in-person or via on-
demand telephone or video conferencing technology. These services should also be 
advertised to all patients to promote their utilization and the patients’ overall comfort 
while receiving care. 
         While most fertility clinics offer interpreter services free of charge, some may 
charge an additional fee to bring in a trained interpreter. This could pose an additional 
barrier for Hispanic and minority patients, who may not be able to afford the extra cost of 
an interpreter. According to Rose et al., specialty physicians were less likely to use 
trained interpreters or telephone services, as they were less available in these fields than 
HMO physicians (2010). The low availability of qualified medical interpreters, especially 
within specialty fields, demonstrates an additional challenge for Hispanic women seeking 
infertility treatment. Lack of access to an interpreter may prevent these women from 
seeking care, adding to the racial and ethnic disparities in the field of ART and further 
impeding the human right to create a family.  
 





One final barrier to adequate ART services among Hispanics is the effect of racial 
stereotyping during medical treatment. To ultimately promote healthcare equity and 
minimize the violation of human rights in medicine, it is imperative to avoid all types of 
bias or stereotyping during treatment. These beliefs or actions could lead to unequal 
treatment among different races or groups. According to Missmer, et al., minority women 
were less likely to find a physician with whom they felt comfortable and believed it was 
more difficult to receive treatment due to their race or ethnicity (2011). A 2014 study of 
minority stereotypes among medical professionals found that most nursing and medical 
students possessed stereotypes that minority patients were more likely to be non-
compliant and have risky health behavior and less likely to communicate effectively 
(Bean, et al., 2014). According to Aronson et al., minority groups are at a higher risk for 
unpleasant interactions in the medical field, potentially explaining the lower healthcare 
utilization rates and poorer health among these populations (2013). Aronson et al. also 
clarify that physicians’ awareness of existing racial stereotypes may result in unintended 
bias, which may negatively affect their interactions with these populations. These 
stereotypes may have many adverse effects on the patient, contributing to poorer health 
(2013). If a patient has previous experience receiving unpleasant treatment, they are less 
likely to seek medical care in the future and may not effectively communicate their health 
concerns with their providers. (Aronson et al., 2013). 
To overcome these unintended biases and stereotype threats, Aronson et al., 
suggest treating all patients with equal empathy and friendliness, no matter their race, 
appearance, or socioeconomic status. They also explain that hiring minority employees or 





groups could help decrease bias in the workplace (2013). Since ART is relatively 
invasive and personal, it is essential to avoid all types of stereotype threat. Maintaining a 
warm, welcoming, and personable demeanor can better help a physician serve patients 
from all backgrounds. Physicians should be sure to stress the normalcy of a patient’s 
concerns and effectively work with them, clearly communicating to construct a thorough 
treatment plan (Aronson et al., 2013). Since Jain (2006) reported that racial 
discrimination is a significant potential barrier to effective infertility treatment, ART 
specialists should do their best to avoid stereotypes, including implicit and explicit bias. 
The elimination of these stereotypes can better allow teams of competent professionals to 
treat minority patients, further narrowing racial disparities in assisted reproductive 
technology in the United States. 
 
XI. Discussion 
Increasing awareness of the disparities and barriers to assisted reproductive 
technology among Hispanic and other minority populations in the United States can help 
promote these populations’ human rights. Since the American Society of Reproductive 
Medicine considers creating a family a fundamental human right, all possible actions 
must be taken to promote this ability, especially among populations that experience 
greater difficulty in conception or those with heightened barriers in access to healthcare. 
Missmer et al. report that more women would seek infertility care if access to these 
services were equal, especially women with lower education and income levels (2011). 
To promote equal access to reproductive care, geographic, socioeconomic, and cultural 





falls on the physicians, policymakers, and insurance providers to abolish the existing 
barriers to infertility treatment. Efforts should also be made to increase insurance 
coverage for these procedures, improve awareness of the current racial and ethnic 
disparities, and reach these underserved minority populations. (Ethics Committee of the 
American Society for Reproductive Medicine, 2015). Analyzing the uneven rates of 
utilization between racial groups illuminates the inequalities in access to care. Hispanic 
women are less likely to receive this essential treatment due to socioeconomic, 
geographic, and cultural barriers that must be abolished. If access to care was universal, 
Hispanic and minority groups would have much higher utilization rates, especially since 
they may be more likely to experience complications with conception in the first place. 
Many steps need to be taken to promote the use of treatment among minority 
groups. Health insurance coverage should be reformed to include the costs of infertility 
treatments, especially for women who cannot conceive or face additional economic 
barriers. This would help make treatment more affordable and less prone to 
socioeconomic disparity. Educational programs should also be created to inform minority 
groups about the availability of ART procedures and sexual wellness to prevent 
complications such as STIs that can potentially affect fertility. In hospitals and clinics, 
healthcare providers need to be educated about the prevention and avoidance of ethnic 
and cultural bias that may be preventing minority groups from receiving care. Trained 
language interpreters must also be available to accommodate patients, helping them feel 
more comfortable seeking infertility care. Taking these steps can promote the use of ART 





conceive a child successfully. Breaking these barriers is vital in the fight for social justice 
and healthcare equity in the United States. 
 
XII. Conclusion 
Assisted Reproductive Technology consists of various forms of treatment used to 
help those who experience fertility complications. These treatments include in vitro 
fertilization, gamete and zygote intrafallopian transfer, and frozen embryo transfer. Since 
reproductive medicine is a very specialized field, it is highly prone to disparity. Hispanic 
women have been found to show an increased need for reproductive treatments due to the 
higher incidence of reproductive complications such as uterine fibroids and tubal factor 
infertility. Their increased likelihood of STIs including chlamydia also leads to decreased 
fertility, ultimately leading to the potential need for reproductive interventions. 
Accessible sexual education programs for minority populations could play a role in 
reducing the transmittance of STIs and avoid possible reproductive complications in the 
future. 
Hispanic Americans show a decreased rate of utilization compared to the general 
population. Hispanic women are less likely to seek specialized treatments for a variety of 
reasons. Specialized medical care is often unevenly centralized in large cities, making it 
hard for rural residents to find appropriate treatment options. Furthermore, reproductive 
clinics are found in more affluent white communities, making it difficult for Hispanic 
women, especially those of lower socioeconomic status, to receive care. The low 
percentage of practicing Hispanic physicians also contributes to the limited reproductive 





usually covered by insurance. Since the Hispanic population exhibits a lower average 
annual household income than whites, it is much harder for many of them to afford 
specialized treatment. This minority population also exhibits lower education levels, 
contributing to lower socioeconomic status and the lack of sexual education and 
increased rates of STIs and infertility. 
Other factors preventing Hispanic Americans from receiving infertility care 
include social stigmas, cultural expectations, and communication barriers in the clinical 
setting. Hispanic Americans often demonstrate religious values that stress the importance 
of creating a family and may experience shame and embarrassment if troubles conceiving 
arise. These negative feelings may prevent them from seeking care, which could be 
avoided with educational programs and additional social support to lower the negative 
stigma surrounding ART procedures. Hispanic Americans are also less likely to seek 
specialized care due to fears of bias and stereotypes on the part of the provider. The low 
utilization of trained medical interpreters also contributes to the fear and discomfort that 
Spanish speakers may have when seeking medical care. These problems can be corrected 
with increased professional training and competencies about avoiding bias when 
providing care. Training programs for medical interpreters and physicians can help 
decrease discrimination and promote infertility services among Hispanic populations. 
Paying particular attention to the factors that limit the use of ART among minority groups 
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